• Department of Respiratory Medicine,Xijing Hospital,Fourth Military Medical University.Xi’an,Shanxi,710032,ChinaCorresponding author:E-mail:changgui@fmmu.edu.cn;
WU Changgui, Email: changgui@fmmu.edu.cn
Export PDF Favorites Scan Get Citation

Objective  To evaluate short-term effects of percutaneous microwave coagulation therapy(PMCT) combined with chemotherapy in patients with advanced non-small cell lung cancer(NSCLC).Methods  Eighty cases with advanced NSCLC were randomly assigned to underwent chemotherapy plus PMCT(PMCT group,n=40) or single chemotherapy(chemotherapy group,n=40).The chemotherapeutics regimen was Taxotere plus Cisplatin.The preliminary results and quality of life score of two groups were compared.Results  In PMCT group and chemotherapy group,the 3-month relieve rate was 52.5% and 32.5%,and the half-year survival rate was 87.5% and 62.5%,respectively.The differences between the two groups were both significant(P lt;0.05).The quality of life score in PMCT group was significantly higher than that in chemotherapy group (P lt;0.05).Conclusion  PMCT combined with chemotherapy is effective and safe in the treatment of advanced NSCLC.

Citation: TI Xinyu ,LI Shengqing,LIU Aru,OUYANG Haifeng,ZHAO Feng,WU Changgui. Short-term effects of percutaneous microwave coagulation therapy combined with chemotherapy in the treatment of advanced non-small cell lung cancer. Chinese Journal of Respiratory and Critical Care Medicine, 2008, 08(3): 174-176. doi: Copy

  • Previous Article

    Construction of China’s Rural Medical Assistance Model: An Evidence-based Approach
  • Next Article

    Construction of China’s Rural Medical Assistance Model: An Evidence-based Approach